ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "axial spondyloarthritis"

  • Abstract Number: 2774 • 2019 ACR/ARP Annual Meeting

    Cluster-based Spondyloarthritis Phenotypes Defined at Baseline Are Predictive of Different Severity Outcomes at 5-Year in the DESIR Cohort

    Félicie Costantino 1, Philippe Aegerter 2, Anna Moltó 3, Georg Schett 4, Maxime Breban 5 and Maria-Antonietta D'Agostino6, 1UMR1173, INSERM/Versailles-Saint Quentin University, France Ambroise Paré Hospital (AP-HP) Department of Rheumatology, Boulogne-Billancourt, France, Boulogne Billancourt, France, 2Public Health Department - GIRCI IdF - INSERM/Versailles-Saint Quentin University, France, Versailles, France, 3Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 4Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 5UMR1173, INSERM/Versailles-Saint Quentin University, France Ambroise Paré Hospital (AP-HP) Department of Rheumatology, Boulogne-Billancourt, France, Boulogne Billancourt, 6UMR1173, INSERM/Versailles-Saint Quentin University, France Ambroise Paré Hospital (AP-HP) Department of Rheumatology, Boulogne Billancourt, France

    Background/Purpose: The course of axial spondyloarthritis (SpA) is heterogeneous and remains to be better defined. DESIR is a longitudinal French cohort of early undifferentiated axial…
  • Abstract Number: 562 • 2019 ACR/ARP Annual Meeting

    Development of a Set of ASAS Quality Standards for Adults with Axial Spondyloarthritis

    Uta Kiltz1, Robert B.M. Landewé 2, Désirée van der Heijde 3, Martin Rudwaleit 4, Michael Weisman 5, Nurullah Akkoç 6, Annelies Boonen 7, Jan Brandt-Jürgens 8, Philippe Carron 9, Maxime Dougados 10, Laure Gossec 11, Merryn Jongkees 12, Pedro Machado 13, Helena Marzo-Ortega 14, Anna Molto 15, Victoria Navarro-Compán 16, Karin Niedermann-Schneider 17, Percival Degrava Sampaio-Barros 18, Gleb Slobodin 19, Filip Van den Bosch 9, Astrid van Tubergen 20, Salima van weely 21, Dieter Wiek 22 and Jürgen Braun 23, 1Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 2Amsterdam University Medical Center, Amsterdam, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Klinikum Bielefeld, Charité Berlin, Gent University, Bielefeld, Germany, 5David Geffen School of Medicine at UCLA, Los Angeles, CA, 6Division of Rheumatology, Celal Bayar University School of Medicine, Manisa, Turkey, Manisa, Turkey, 7Maastricht University Medical Center, Maastricht, Netherlands, 8Rheumatologische Schwerpunktpraxis, Berlin, Germany, 9Ghent University Hospital, Ghent, Belgium, 1010Rheumatology B Department, Paris Descartes University, Cochin Hospital, Paris, France, 11Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France, 12seaynmedical, Netherlands, Netherlands, 13Centre for Rheumatology & MRC Centre for Neuromuscular Diseases, University College London, London, United Kingdom, 14NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, Leeds, Leeds, United Kingdom, 15Paris Descartes University, Medicine Faculty; APHP, Rheumatology, Hôpital Cochin, Hôpitaux de Paris, Paris, Paris, France, 16University Hospital La Paz, IdiPaz, Madrid, Spain, 17ZHAW Gesundheit Institut für Physiotherapie, Winterthur, Switzerland, 18Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Brazil, Sao Paulo, Brazil, 1918Department of Internal Medicine A, Bnai Zion Medical Center, Technion, Haifa, Israel, 20Maastricht University Medical Centre and Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands, 21Orthopedics, Rehabilitation and Physical Therapy dpt., Leiden University Medical Center, Leiden, Netherlands, 22patient research partner, Germany, Germany, Germany, 23Rheumazentrum Ruhrgebiet/Ruhr University, Herne, Germany

    Background/Purpose: There is wide variation in the management of patients with axial spondyloarthritis (axSpA) worldwide with significant unmet needs such as delayed diagnosis. One way…
  • Abstract Number: 601 • 2019 ACR/ARP Annual Meeting

    Development of an Optimized Online Self-Referral Tool for Early Recognition of Patients with Axial Spondyloarthritis – Data from the OptiRef Study

    Fabian Proft1, Laura Spiller 2, Mikhail Protopopov 3, Valeria Rios Rodriguez 2, Burkhard Muche 2, Judith Rademacher 2, Susanne Lüders 2, Anne Katrin Weber 2, Imke Redeker 4 and Denis Poddubnyy 5, 1Charité Universitätsmedizin Berlin, Germany, Berlin, Germany, 2Charité Universitätsmedizin, Berlin, Germany, 3Charité Universitätsmedizin Berlin, Germany, Berlin, Berlin, Germany, 4Charité – Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, 5Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany

    Background/Purpose: One of the major reasons for a long diagnostic delay in axial spondyloarthritis (axSpA) is the late referral of patients by primary care physicians…
  • Abstract Number: 635 • 2019 ACR/ARP Annual Meeting

    Association Between Radiographic Progression and Cardiovascular Risk in Spondyloarthritis: Data from CoSpaR REGISTRY

    María Lourdes Ladehesa-Pineda1, Maria Carmen Castro 2, Ignacio Gomez-Garcia 2, Pedro Seguí-Azpilcueta 3, María del carmen ábalos-Aguilera 4, Rocío Segura-Ruiz 5, Rafaela Ortega 2, Laura Bautista-Aguilar 6, Inmaculada Aranda-Varela 7, Clementina López-Medina 8, Juan Luis Garrido-Castro 9, Chary Lopez-Pedrera 2, Alejandro Escudero-Contreras 7, Eduardo Collantes-Estévez 7 and Yolanda Jiménez-Gómez 4, 1Universitary Hospital Reina Sofia of Cordoba/University of Cordoba/IMIBIC, Córdoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Universitary Hospital Reina Sofía of Córdoba, Córdoba, Spain, 4IMIBIC, Córdoba, Spain, 5Reina Sofia University Hospital/IMIBIC, Córdoba, Spain, 6[email protected], Córdoba, Spain, 7Universitary Hospital Reina Sofía of Córdoba/University of Córdoba/IMIBIC, Córdoba, Spain, 8Cochin Hospital, Rheumatology Department, Paris, France, 9University of Córdoba, Córdoba, Spain

    Background/Purpose: Our objectives are:To analyze the prevalence of comorbidities related to CV risk in a register of patients with spondyloarthritis (CoSpaR).To evaluate if there is…
  • Abstract Number: 1478 • 2019 ACR/ARP Annual Meeting

    Systematic Literature Review and Network Meta-Analysis Comparing Incidence of Uveitis and IBD in Axial Spondyloarthritis Patients Treated with Anti-TNF versus Anti-IL17A in Placebo Controlled Randomized Trials

    Damien Roche1, Martin Badard 1, Laurent Boyer 2, Pierre Lafforgue 1 and Thao Pham 1, 1Aix-Marseille University, CHU Marseille, department of Rheumatology, 13,000 Marseille, France, Marseille, France, 2Aix-Marseille University, EA 3279 Research Unit, 13,000 Marseille, France, Marseille, France

    Background/Purpose: Inflammatory bowel diseases (IBD) and anterior uveitis (AU) are frequent extra-articular features of axial spondyloarthritis (axSpA). Although effect of anti-TNF on IBD and AU…
  • Abstract Number: 1546 • 2019 ACR/ARP Annual Meeting

    Effectiveness and Retention Rate of Secukinumab for Psoriatic Arthritis and Axial Spondyloarthritis: Real-life Data from the Italian LORHEN Registry

    Ennio Giulio Favalli 1, Antonio Marchesoni 1, Silvia Balduzzi 2, Carlomaurizio Montecucco 3, Claudia Lomater 4, Gloria Crepaldi 4, Silvia Tamanini 5, Chiara Bazzani 6, Enrico Fusaro 7, Marta Priora 7, Aurora Ianniello 8 and Roberto Caporali1, 1University of Milan, Department of Rheumatology, ASST Gaetano Pini-CTO, Milan, Lombardia, Italy, 2Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy, Pavia, Lombardia, Italy, 3Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy, Pavia, Italy, 4AO Ordine Mauriziano, SSD Reumatologia, Torino, Turin, Piemonte, Italy, 5ASST Spedali Civili and University of Brescia, Milan, Lombardia, Italy, 6Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy, Brescia, Italy, 7A.O.U. Città della Salute e della Scienza di Torino, SC Reumatologia, Turin, Piemonte, Italy, 8Day Hospital Multidisciplinare PO SS. Trinità, Borgomanero, Borgomanero, Piemonte, Italy

    Background/Purpose: Observational data on the use of secukinumab for the treatment of spondyloarthritides are still lacking. The aim of this study is to evaluate the…
  • Abstract Number: 2775 • 2019 ACR/ARP Annual Meeting

    Pregnancy Rates and Outcomes in Early Axial Spondyloarthritis: Analysis of the DESIR Cohort

    Marion Pons 1, Nathalie Costedoat-Chalumeau 2, Karine Briot 3, Philippe Goupille 4, Christian Roux 5, Maxime Dougados 6 and Anna Moltó5, 1Rheumatology department, Cochin Hospital, Paris, Paris, Ile-de-France, France, 2Cochin University Hospital, Paris, France, 3Rheumatology department, Cochin Hospital, Paris, France, Paris, Ile-de-France, France, 4Tours University-Hospital, Tours, France, Tours, France, 5Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 6Cochin Hospital, Paris, France

    Background/Purpose: Only scarce data is available on regarding pregnancy rates and pregnancy outcomes in early axial spondyloarthritis (axSpA). The objectives of this study were to…
  • Abstract Number: 563 • 2019 ACR/ARP Annual Meeting

    The Impact of Sex and Disease Classification on Patient-reported Outcome Measures in Axial Spondyloarthritis: A Descriptive Prospective Cross-sectional Study

    Rikke Andreasen1, Lars Erik Kristensen 2, Kenneth Egstrup 1, Xenofon Baraliakos 3, Vibeke Strand 4, Hans Christian Horn 5, Inger Marie Hansen 1, Robin Christensen 6 and Torkell Ellingsen 7, 1Odense University Hospital, Svendborg, Svendborg, Denmark, 2Musculoskeletal Statistics Unit, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Copenhagen, Denmark, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany, Herne, Germany, 4Division of Immunology/Rheumatology, Stanford University, Stanford, CA, 5Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark, Odense, Denmark, 6Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital & Department of Rheumatology, Institute of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark, 7Department of Rheumatology, Odense University Hospital, Denmark, Odense, Syddanmark, Denmark

    Background/Purpose: To explore the impact of sex and disease classification on outcomes in axial spondyloarthritis (axSpA) patients, including both ankylosing spondylitis (AS) and non-radiographic (nr-)…
  • Abstract Number: 603 • 2019 ACR/ARP Annual Meeting

    Are the Modified New York and ASAS Criteria Interchangeable in the Classification of Patients with Spondyloarthritis with Radiographic Sacroiliitis?

    Anne Boel1, Anna Moltó 2, Désirée van der Heijde 3, Adrian Ciurea 4, Maxime Dougados 5, Lianne Gensler 6, Maria José Santos 7, Eugenio de Miguel 8, Denis Poddubnyy 9, Martin Rudwaleit 10, Astrid van Tubergen 11, Floris van Gaalen 3 and Sofia Ramiro 12, 1Leiden University Medical Centre, Leiden, Netherlands, 2Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 3Leiden University Medical Center, Leiden, Netherlands, 4University Hospital Zürich, Zürich, Switzerland, 5Cochin Hospital, Paris, France, 6University San Francisco California, San Francisco, CA, 7Rheumatology department, Hospital Garcia de Orta, Almada, Portugal, 8Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 9Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany, 10Klinikum Bielefeld, Charité Berlin, Gent University, Bielefeld, Germany, 11Maastricht University Medical Centre and Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands, 12Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands

    Background/Purpose: Patients with axial spondyloarthritis (axSpA) with radiographic sacroiliitis may be classified using the modified New York (mNY) criteria as ankylosing spondylitis and using the…
  • Abstract Number: 748 • 2019 ACR/ARP Annual Meeting

    Takayasu Arteritis and Sacroiliitis: A Case Control Study in 28 Patients of a Single Italian Center

    Paola Toniati1, Francesca Regola 1, Franco Franceschini 1, Giovanni Bosio 2 and Angela Tincani 3, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, Brescia, Italy, 2Nuclear Medicine Unit, ASST Spedali Civili of Brescia, Brescia, Italy, Brescia, Italy, 3Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Brescia, Italy

    Background/Purpose: A lot of clinical case descriptions about spondyloarthropathy in TAK patients were reported. Recently, a paper about an increased incidence of spondyloarthropathy in TAK…
  • Abstract Number: 1482 • 2019 ACR/ARP Annual Meeting

    Secukinumab Provides Sustained Improvement of Enthesitis in Ankylosing Spondylitis Patients: A Pooled Analysis of Four Pivotal Phase 3 Trials

    Georg Schett1, Xenofon Baraliakos 2, Filip Van den Bosch 3, Atul Deodhar 4, Lianne Gensler 5, Mikkel Østergaard 6, Shital Agawane 7, Ayan Das Gupta 7, Shephard Mpofu 8, Todd Fox 8, Adam Winseck 9, Brian Porter 9 and Abhijit Shete 8, 1Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 2Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, 3Ghent University Hospital, Ghent, Belgium, 4Oregon Health & Science University, Portland, OR, 5University San Francisco California, San Francisco, CA, 6Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 7Novartis Healthcare Pvt Ltd, Hyderabad, India, 8Novartis Pharma AG, Basel, Switzerland, 9Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Enthesitis can be a debilitating spondyloarthritis (SpA) manifestation and the cause of pain, reduced quality of life and impaired physical function.1,2 Herein, we evaluated…
  • Abstract Number: 1547 • 2019 ACR/ARP Annual Meeting

    Ixekizumab Improves Self-reported Overall Functioning and Health as Measured by the Assessment of SpondyloArthritis International Society Health Index in Patients with Active Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Randomized Trials

    Uta Kiltz1, Désirée van der Heijde 2, Annelies Boonen 3, Lianne Gensler 4, Theresa Hunter 5, Fangyi Zhao 6, Baojin Zhu 5, Rebecca Bolce 5, Hilde Carlier 5 and Jürgen Braun 7, 1Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 2Leiden University Medical Center, Leiden, Netherlands, 3Maastricht University Medical Center, Maastricht, Netherlands, 4University San Francisco California, San Francisco, CA, 5Eli Lilly and Company, Indianapolis, 6Eli Lilly and Company, Indianapolis, IN, 7Rheumazentrum Ruhrgebiet/Ruhr University, Herne, Germany

    Background/Purpose: The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) measures health, disability, and functioning in patients (pts) with spondyloarthritis (SpA)[1,2]. The purpose of…
  • Abstract Number: 2776 • 2019 ACR/ARP Annual Meeting

    5-years Treatment Effect of TNF Alpha Inhibitor in Early Axial Spondyloarthritis and Associated Factors: An Inverse Probability Weighting Analysis of the DESIR Cohort

    Marion Pons 1, Sylvie Chevret 2, Karine Briot 1, Maria-Antonietta D’Agostino 3, Christian Roux 4, Maxime Dougados 5 and Anna Moltó4, 1Rheumatology department, Cochin Hospital, Paris, Paris, Ile-de-France, France, 2INSERM U-1153, CRESS Paris-Sorbonne, Paris, Paris, Ile-de-France, France, 3Department of Rheumatology, APHP, Hôpital Ambroise Paré, Paris, France, 4Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 5Cochin Hospital, Paris, France

    Background/Purpose: Only scarce date is available on the long term treatment effect in a real-life setting (i.e. effectiveness) of TNFi in early axial SpA forms…
  • Abstract Number: 567 • 2019 ACR/ARP Annual Meeting

    Worse Outcomes for Female Patients with Axial Spondyloarthropathy

    Sinead Maguire1, Gillian Fitzgerald 2, Claire Sheehy 3 and Finbar O'Shea 2, 1University Hospital Waterford, Dublin, Ireland, 2St James' Hospital, Dublin, Ireland, 3University Hospital Waterford, Waterford, Ireland

    Background/Purpose: Axial Spondyloarthritis(axSpA) is known to have a male predominance. There is little available literature examining affected female patients. Previous studies have included small numbers…
  • Abstract Number: 604 • 2019 ACR/ARP Annual Meeting

    Do Illness Perceptions and Coping Change over Time in Patients Recently Diagnosed with Axial Spondyloarthritis? A 2-Year Follow-Up Study in the SPACE Cohort

    Miranda van Lunteren1, Robert B.M. Landewé 2, Camilla Fongen 3, Roberta Ramonda 4, Désirée van der Heijde 1 and Floris van Gaalen 1, 1Leiden University Medical Center, Leiden, Netherlands, 2Amsterdam University Medical Center, Amsterdam, Netherlands, 3Diakonhjemmet Hospital, Oslo, Norway, 4University of Padova, Padova, Italy

    Background/Purpose: We have previously shown that in patients with recently diagnosed axial SpA (axSpA), illness perceptions had a negative impact on the relationship between back…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology